CDCES EXAM QUESTIONS WITH 100% CORRECT ANSWERS 2024 LATEST UPDATE
4 views 0 purchase
Course
CDCES
Institution
CDCES
CDCES EXAM QUESTIONS WITH 100% CORRECT ANSWERS 2024 LATEST UPDATE
How long does it take to see the maximal effect of a TZD?
A. 2 weeks
B. 4 weeks
C. 6 weeks
D. ≥8 weeks - Answer- D.
TZDs and CHF - Answer- TZDs are known for their association with fluid accumulation, which results in w...
CDCES EXAM QUESTIONS WITH
100% CORRECT ANSWERS 2024
LATEST UPDATE
How long does it take to see the maximal effect of a TZD?
A. 2 weeks
B. 4 weeks
C. 6 weeks
D. ≥8 weeks - Answer- D.
TZDs and CHF - Answer- TZDs are known for their association with fluid accumulation,
which results in weight gain, potentially caused by an increase in subcutaneous adipose
tissue and concomitant disease in visceral fat, as well as an increase in leptin levels
resulting in increased appetite. Furthermore, fluid retention is not only a contributor to
weight gain, but also a precipitator of CHF exacerbation. Both available TZDs,
pioglitazone and rosiglitazone, carry a black-box warning about their potential to cause
or exacerbate CHF. The weight gain and fluid accumulation seen with TZDs are dose-
dependent; therefore, when there is concern about potential fluid accumulation and
CHF exacerbation, lower doses should be used.
TZDs and CV outcomes - Answer- pioglitazone can offer improved CV outcomes in
patients with type 2 diabetes who are at high CV risk.
Sulfonylurea side effects - Answer- Sulfonylureas are known for increasing the risks of
weight gain and hypoglycemia and for being associated with a theoretical concern
regarding potential increased CV risk.
Sulfonylureas method of action - Answer- Sulfonylureas stimulate insulin secretion from
pancreatic β-cells. Because this effect does not occur in a glucose-dependent manner,
these agents can cause hypoglycemia, especially in patients with erratic eating
schedules.
iGlarLixi Dosing - Answer- The recommended starting dose of iGlarLixi is insulin
glargine/lixisenatide 15 units/5 μg once daily for patients who are naive to basal insulin
or GLP-1 receptor agonists, currently on a GLP-1 receptor agonist, or currently on <30
units of basal insulin daily. For patients on 30-60 units of basal insulin daily with or
without a GLP-1 receptor agonist, the recommended starting dose is insulin
glargine/lixisenatide 30 units/10 μg once daily. The iGlarLixi pen is designed for dialing
, up doses based on the insulin units. Every 1 unit of iGlarLixi 100/33 contains 1 unit of
insulin glargine and 0.33 μg of lixisenatide. Doses should be titrated by 2-4 units weekly
based on the degree to which the patient' FPG is above or below the target range. The
maximum recommended dose of iGlarLixi is insulin glargine/ lixisenatide 60 units/20 μg
once daily.
pre-recs for CGM - Answer- -The patient has a documented diagnosis of diabetes
-The patient has been performing frequent SMBG (at least four times daily)
-The patient is on insulin therapy with at least three daily injections or uses an insulin
pump
-The insulin regimen requires frequent adjustment based on therapeutic CGM testing
results
-Within 6 months before ordering the CGM device, the patient had an in-person visit
with the treating practitioner to evaluate diabetes control and determine whether the
above criteria had been met
-Every 6 months after the initial CGM prescription, the patient has an in-person visit with
the treating practitioner to assess adherence to the CGM regimen and diabetes
treatment plan
partially blocks potassium channels among beta cells of pancreatic islets of
Langerhans. This causes the cell to depolarize, causing opening of voltage-gated
calcium channels. Calcium influx encourages insulin release from beta cells.
Invokana - Answer- Canagliflozin
SGLT-2 inhibitor
inhibits sodium-glucose co-transporter 2 in the kidney to reduce glucose reabsorption,
resulting in increased glucose excretion & lower plasma glucose
Metformin - Answer- Glucophage
biguanide
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Scholarsstudyguide. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $12.49. You're not tied to anything after your purchase.
